1 Thigpen SC,Geraci SA.Cancer screening.2016.Am J Med Sci,2016,352:493-501.
2 中国女医师协会临床肿瘤学专业委员会;中国抗癌协会乳腺癌专业委员会.中国进展期乳腺癌共识指南(CABC 2015).癌症进展,2015,13:223-245.
3 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2013 版) .中国癌症杂志,2013,23:637-684.
4 American College of Radiology.Illustrated Breast Imaging Reporting and Data System ( BI-RADS).2016-04-20.[www.acr.org /Quality -Satety /Resources /BIRADS]
5 李毅,吕艳丽,赵越,等.超声和X线检查对乳腺病变的诊断效能分析.中华乳腺病杂志:电子版,2016,10:295-299.
6 Jiang L,Ma T,Moran MS,et al.Mammographic features are associated withclinicopathological characteristics in invasive breast cancer.Anticancer Res,2011,31:2327-2334.
7 蒋珍妮,林青,齐春华,等.乳腺癌HER2表达与乳腺X线及超声影像表现的相关性分析.现代生物医学进展,2014,14:4237-4243.
8 董朝,任光辉,耿中利,等.三阴性乳腺癌临床病理特点及与 ki67 表达关系的分析.中国妇幼保健,2012,27:5784-5786.
9 Lauby-Secretan B,Scoccianti C,Loomis D,et al.Breast-cancer screening -viewpoint of the IARC Working Group.N Engl J Med,2015,372:2353-2358.
10 Sihto H,Lundin J,Lehtimaki T,et al.Molecular subtypes of breast cancers detected in mammography screening and outside of screening.Clin Cancer Res,2008,14:4103-4110.
11 韩晓蓉,连臻强,杨剑敏,等.超声、X线及MRI对不同分子亚型乳腺癌的诊断价值.中国妇幼保健,2014,29:457-460.